Quarterly report pursuant to Section 13 or 15(d)

Licenses (Details Narrative)

v3.24.2.u1
Licenses (Details Narrative) - USD ($)
6 Months Ended
May 15, 2024
Jun. 30, 2024
Jun. 30, 2023
Purchase price of license fair value   $ 75,000
Petalo Pharmaceutical, S.A.S [Member]      
Purchase price of license fair value $ 75,000